logo
  

Stock Alert: Travelers Hits New 52-week High As Q4 Profit Beats View

Shares of Travelers Companies Inc. (TRV), a provider of insurance products and services, are rising almost 4 percent or $5.37 in Thursday's morning trade at $150.39, after touching a new 52-week high of $152.29.

Thursday, Travelers reported fourth-quarter net income of $1.31 billion or $5.10 per share, up from $873 million or $3.35 per share in the previous-year quarter. Core income was $4.91 per share, compared to $3.32 per share in the prior year quarter. Total revenues grew 4 percent to $8.40 billion from $8.06 billion last year. Net written premiums increased 3 percent to $7.27 billion from $7.08 billion last year.

Analysts polled by Thomson Reuters had a consensus estimate for earnings of $3.18 per share on revenues of $7.27 billion.

Travelers has traded in a range of $76.99 to $152.29 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT